{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:51:11Z","timestamp":1792039871553,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10646-7","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T18:55:26Z","timestamp":1740855326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence and predictors of loss to follow-up among adult HIV patients attending antiretroviral therapy at public health facilities in Agaro town, Southwest Ethiopia, 2023"],"prefix":"10.1186","volume":"25","author":[{"given":"Abduljebar Mohammed","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assefa Legesse","family":"Sisay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamo Nigatu","family":"Gebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"2","key":"10646_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.15294\/ujph.v7i2.20901","volume":"7","author":"TL Boro","year":"2018","unstructured":"Boro TL, Paun R, Pellokila MR. Factors of loss to Follow-Up antiretroviral therapy in Islanded Area. Unnes J Public Health. 2018;7(2):98\u2013103.","journal-title":"Unnes J Public Health"},{"issue":"1","key":"10646_CR2","first-page":"62","volume":"5","author":"A Agbor","year":"2021","unstructured":"Agbor A, Gael B, Brian A. Predictors of loss to follow-up in patients on antiretroviral treatment in Centre Hospitalier Essos, Cameroon. Clin J HIV AIDS. 2021;5(1):62\u20139.","journal-title":"Clin J HIV AIDS"},{"issue":"5","key":"10646_CR3","doi-asserted-by":"publisher","first-page":"e0251648","DOI":"10.1371\/journal.pone.0251648","volume":"16","author":"A Aemro","year":"2021","unstructured":"Aemro A, Wassie M, Chekol B. Incidence and predictors of mortality within the first year of antiretroviral therapy initiation at Debre-Markos Referral Hospital, Northwest Ethiopia: a retrospective follow up study. PLoS ONE. 2021;16(5):e0251648.","journal-title":"PLoS ONE"},{"issue":"1","key":"10646_CR4","doi-asserted-by":"publisher","first-page":"e0222309","DOI":"10.1371\/journal.pone.0222309","volume":"15","author":"R Makurumidze","year":"2020","unstructured":"Makurumidze R, Mutasa-Apollo T, Decroo T, et al. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe\u2019s national antiretroviral therapy programme between 2012 and 2015. PLoS ONE. 2020;15(1):e0222309.","journal-title":"PLoS ONE"},{"issue":"6","key":"10646_CR5","doi-asserted-by":"publisher","first-page":"e0179533","DOI":"10.1371\/journal.pone.0179533","volume":"12","author":"HA Gesesew","year":"2017","unstructured":"Gesesew HA, Ward P, Woldemichael K, Mwanri L. Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003\u20132015. PLoS ONE. 2017;12(6):e0179533.","journal-title":"PLoS ONE"},{"issue":"1","key":"10646_CR6","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1097\/QAD.0000000000002983","volume":"35","author":"K Heath","year":"2021","unstructured":"Heath K, Levi J, Hill A. The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture. AIDS. 2021;35(1):S197\u2013203.","journal-title":"AIDS"},{"key":"10646_CR7","unstructured":"COP ECOP. Strategic direction summary. 2021."},{"key":"10646_CR8","unstructured":"Organization WH. Progress report 2016: prevent HIV, test and treat all: WHO support for country impact. World Health Organization; 2016."},{"issue":"1","key":"10646_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0272684X221094151","volume":"44","author":"T Shimels","year":"2023","unstructured":"Shimels T, Kassu RA, Bogale G, et al. Adherence to antiretroviral medications among people living with HIV in the era of COVID-19 in Central Ethiopia and Perceived Impact of the pandemic. Community Health Equity Res Policy. 2023;44(1):99\u2013107.","journal-title":"Community Health Equity Res Policy"},{"issue":"9","key":"10646_CR10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/QAD.0000000000002523","volume":"34","author":"EM Frijters","year":"2020","unstructured":"Frijters EM, Hermans LE, Wensing AM, Devill\u00e9 WL, Tempelman HA, De Wit JB. Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries. Aids. 2020;34(9):1261\u201388.","journal-title":"Aids"},{"key":"10646_CR11","unstructured":"Kaara F. Factors Associated with loss to follow up of HIV patients living with HIV in Kiambu County Referral Hospital. JKUAT-COHES; 2021."},{"issue":"1","key":"10646_CR12","first-page":"1","volume":"9","author":"GJ Kibet","year":"2022","unstructured":"Kibet GJ, Arudo J, Ashivira C, et al. The incidence rate and Health-Care Factors Associated with LTFU, among adult patients initiated on ART in Nakuru West Sub-county Health Facilities, Kenya. Open Access Libr J. 2022;9(1):1\u201317.","journal-title":"Open Access Libr J"},{"key":"10646_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-saharan Africa. AIDS. 2008;22:15.","journal-title":"AIDS"},{"issue":"1","key":"10646_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-3156.2011.02889.x","volume":"17","author":"AS Hassan","year":"2012","unstructured":"Hassan AS, Fielding KL, Thuo NM, Nabwera HM, Sanders EJ, Berkley JA. Early loss to follow-up of recently diagnosed HIV\u2010infected adults from routine pre\u2010ART care in a rural district hospital in Kenya: a cohort study. Tropical Med Int Health. 2012;17(1):82\u201393.","journal-title":"Tropical Med Int Health"},{"issue":"9","key":"10646_CR15","doi-asserted-by":"publisher","first-page":"e0183823","DOI":"10.1371\/journal.pone.0183823","volume":"12","author":"SG Agolory","year":"2017","unstructured":"Agolory SG, Auld AF, Odafe S, et al. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004\u20132012. PLoS ONE. 2017;12(9):e0183823.","journal-title":"PLoS ONE"},{"issue":"6","key":"10646_CR16","doi-asserted-by":"publisher","first-page":"e006927","DOI":"10.1136\/bmjopen-2014-006927","volume":"5","author":"M Plazy","year":"2015","unstructured":"Plazy M, Orne-Gliemann J, Dabis F, Dray-Spira R. Retention in care prior to antiretroviral treatment eligibility in sub-saharan Africa: a systematic review of the literature. Bmj Open. 2015;5(6):e006927.","journal-title":"Bmj Open"},{"key":"10646_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4154-y","volume":"12","author":"N Mekonnen","year":"2019","unstructured":"Mekonnen N, Abdulkadir M, Shumetie E, Baraki AG, Yenit MK. Incidence and predictors of loss to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at University of Gondar comprehensive specialized Hospital Northwest Ethiopia, 2018: retrospective follow up study. BMC Res Notes. 2019;12:1\u20137.","journal-title":"BMC Res Notes"},{"issue":"10","key":"10646_CR18","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1371\/journal.pmed.0040298","volume":"4","author":"S Rosen","year":"2007","unstructured":"Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298.","journal-title":"PLoS Med"},{"key":"10646_CR19","doi-asserted-by":"publisher","first-page":"e25780","DOI":"10.1002\/jia2.25780","volume":"24","author":"R Kassanjee","year":"2021","unstructured":"Kassanjee R, Johnson LF, Zaniewski E, et al. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International Epidemiology Databases to evaluate AIDS collaboration. J Int AIDS Soc. 2021;24:e25780.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10646_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00331-5","volume":"18","author":"E Nuwagira","year":"2021","unstructured":"Nuwagira E, Lumori BA, Muhindo R, et al. Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda. AIDS Res Therapy. 2021;18(1):1\u20139.","journal-title":"AIDS Res Therapy"},{"issue":"6","key":"10646_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/2141-9248.177988","volume":"5","author":"K Eguzo","year":"2015","unstructured":"Eguzo K, Lawal A, Umezurike C, Eseigbe C. Predictors of loss to follow\u2013up among HIV\u2013infected patients in a rural south\u2013eastern Nigeria Hospital: a 5\u2013year Retrospective Cohort Study. Annals Med Health Sci Res. 2015;5(6):373\u20138.","journal-title":"Annals Med Health Sci Res"},{"issue":"1","key":"10646_CR22","doi-asserted-by":"publisher","first-page":"e0227473","DOI":"10.1371\/journal.pone.0227473","volume":"15","author":"AB Teshale","year":"2020","unstructured":"Teshale AB, Tsegaye AT, Wolde HF. Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: a competing risk regression modeling. PLoS ONE. 2020;15(1):e0227473.","journal-title":"PLoS ONE"},{"key":"10646_CR23","doi-asserted-by":"crossref","unstructured":"Zeleke S, Demis S, Tesfahun Y, Munye T, Eshetie Y, Kefale D, et al. Incidence and predictors of loss to follow-up among adults on antiretroviral therapy in south gondar governmental hospitals, ethiopia: retrospective cohort study. J Multidiscip Healthc. 2023;16(June):1737\u201348.","DOI":"10.2147\/JMDH.S414194"},{"issue":"1","key":"10646_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3188-4","volume":"18","author":"W Seifu","year":"2018","unstructured":"Seifu W, Ali W, Meresa B. Predictors of loss to follow up among adult clients attending antiretroviral treatment at Karamara general hospital, Jigjiga town, Eastern Ethiopia, 2015: a retrospective cohort study. BMC Infect Dis. 2018;18(1):1\u20138.","journal-title":"BMC Infect Dis"},{"key":"10646_CR25","doi-asserted-by":"crossref","unstructured":"Dessu S, Mesele M, Habte A, Dawit Z. Time until loss to follow-up, incidence, and predictors among adults taking art at public hospitals in southern ethiopia. HIV\/AIDS - Res Palliat Care. 2021;13:205\u201315.","DOI":"10.2147\/HIV.S296226"},{"issue":"1","key":"10646_CR26","doi-asserted-by":"publisher","first-page":"8659372","DOI":"10.1155\/2021\/8659372","volume":"2021","author":"MA Gebremichael","year":"2021","unstructured":"Gebremichael MA, Gurara MK, Weldehawaryat HN, Mengesha MM, Berbada DA. Predictors of loss to Follow-Up among HIV\u2010Infected adults after initiation of the first\u2010line antiretroviral therapy at Arba Minch General Hospital, Southern Ethiopia: a 5\u2010Year retrospective cohort study. Biomed Res Int. 2021;2021(1):8659372.","journal-title":"Biomed Res Int"},{"key":"10646_CR27","unstructured":"Federal Ministry of Health Ethiopia. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and [Internet]. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and. 2018. Available from: https:\/\/www.afro.who.int\/publications\/nationalconsolidated-guidelines-comprehensive-hiv-prevention-care-and-treatment"},{"key":"10646_CR28","doi-asserted-by":"crossref","unstructured":"Gebremichael MA, Gurara MK, Weldehawaryat HN, Mengesha MM, Berbada DA. Predictors of loss to follow-up among HIV-infected adults after initiation of the first-line antiretroviral therapy at Arba Minch General Hospital, Southern Ethiopia: a 5-year retrospective cohort study. Biomed Res Int. 2021;2021.","DOI":"10.1155\/2021\/8659372"},{"key":"10646_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-020-00266-z","volume":"48","author":"MY Birhanu","year":"2020","unstructured":"Birhanu MY, Leshargie CT, Alebel A, et al. Incidence and predictors of loss to follow-up among HIV-positive adults in northwest Ethiopia: a retrospective cohort study. Trop Med Health. 2020;48:1\u201310.","journal-title":"Trop Med Health"},{"issue":"1","key":"10646_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3756-2","volume":"19","author":"KE Gezae","year":"2019","unstructured":"Gezae KE, Abebe HT, Gebretsadik LG. Incidence and predictors of LTFU among adults with TB\/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009\u20132016: survival model approach. BMC Infect Dis. 2019;19(1):1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10646_CR31","doi-asserted-by":"publisher","first-page":"e003499","DOI":"10.1136\/bmjopen-2013-003499","volume":"3","author":"BL H\u00f8nge","year":"2013","unstructured":"H\u00f8nge BL, Jespersen S, Nordentoft PB, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ open. 2013;3(10):e003499.","journal-title":"BMJ open"},{"issue":"4","key":"10646_CR32","doi-asserted-by":"publisher","first-page":"e0217606","DOI":"10.1371\/journal.pone.0217606","volume":"15","author":"J Kiwanuka","year":"2020","unstructured":"Kiwanuka J, Mukulu Waila J, Muhindo Kahungu M, Kitonsa J, Kiwanuka N. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: a retrospective cohort study in Masaka, Uganda. PLoS ONE. 2020;15(4):e0217606.","journal-title":"PLoS ONE"},{"issue":"1","key":"10646_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-019-0241-3","volume":"16","author":"A Aliyu","year":"2019","unstructured":"Aliyu A, Adelekan B, Andrew N, et al. Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004\u20132017). AIDS Res Therapy. 2019;16(1):1\u20139.","journal-title":"AIDS Res Therapy"},{"key":"10646_CR34","doi-asserted-by":"crossref","unstructured":"Dejen D, Jara D, Yeshanew F, Fentaw Z, Feleke TM, Girmaw F, et al. Attrition and its predictors among adults receiving first-line antiretroviral therapy in woldia town public health facilities, northeast ethiopia: a retrospective cohort study. HIV\/AIDS - Res Palliat Care. 2021;13:445\u201354.","DOI":"10.2147\/HIV.S304657"},{"key":"10646_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3407-5","volume":"11","author":"MA Assemie","year":"2018","unstructured":"Assemie MA, Muchie KF, Ayele TA. Incidence and predictors of loss to follow up among HIV-infected adults at Pawi General Hospital, northwest Ethiopia: competing risk regression model. BMC Res Notes. 2018;11:1\u20136.","journal-title":"BMC Res Notes"},{"issue":"2","key":"10646_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4314\/ahs.v22i2.3","volume":"22","author":"WS Shiferaw","year":"2022","unstructured":"Shiferaw WS, Belete AM, Adela A, Getnet M, Aynalem YAAA. Incidence and predictors of loss to follow-up among adult HIV-infected patients taking antiretroviral therapy at North Shewa Zone public hospitals, Northeast Ethiopia: a retrospective follow-up study. Afr Health Sci. 2022;22(2):12\u201326.","journal-title":"Afr Health Sci"},{"issue":"1","key":"10646_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-4474-6","volume":"19","author":"D Opio","year":"2019","unstructured":"Opio D, Semitala FC, Kakeeto A, et al. Loss to follow-up and associated factors among adult people living with HIV at public health facilities in Wakiso district, Uganda: a retrospective cohort study. BMC Health Serv Res. 2019;19(1):1\u201310.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10646_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/hiv.12668","volume":"20","author":"A Bald\u00e9","year":"2019","unstructured":"Bald\u00e9 A, Li\u00e8vre L, Maiga AI, et al. Risk factors for loss to follow-up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali. HIV Med. 2019;20(1):47\u201353.","journal-title":"HIV Med"},{"issue":"10","key":"10646_CR39","doi-asserted-by":"publisher","first-page":"e0223655","DOI":"10.1371\/journal.pone.0223655","volume":"14","author":"D Jerene","year":"2019","unstructured":"Jerene D, Abebe W, Taye K, Ruff A, Hallstrom I. Adolescents living with HIV are at higher risk of death and loss to follow up from care: analysis of cohort data from eight health facilities in Ethiopia. PLoS ONE. 2019;14(10):e0223655.","journal-title":"PLoS ONE"},{"issue":"9","key":"10646_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/1947-2714.141636","volume":"6","author":"TM Berheto","year":"2014","unstructured":"Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV\/AIDS after initiation of antiretroviral therapy. North Am J Med Sci. 2014;6(9):453.","journal-title":"North Am J Med Sci"},{"key":"10646_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-021-00822-7","volume":"10","author":"HK Kebede","year":"2021","unstructured":"Kebede HK, Mwanri L, Ward P, Gesesew HA. Predictors of lost to follow up from antiretroviral therapy among adults in sub-saharan Africa: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10:1\u201318.","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"10646_CR42","doi-asserted-by":"publisher","first-page":"e25460","DOI":"10.1002\/jia2.25460","volume":"23","author":"AV Kalinjuma","year":"2020","unstructured":"Kalinjuma AV, Glass TR, Weisser M, et al. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV\u2010positive adults in rural Tanzania. J Int AIDS Soc. 2020;23(3):e25460.","journal-title":"J Int AIDS Soc"},{"key":"10646_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-8426-1","volume":"20","author":"P Wekesa","year":"2020","unstructured":"Wekesa P, McLigeyo A, Owuor K, Mwangi J, Nganga E, Masamaro K. Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya. BMC Public Health. 2020;20:1\u201311.","journal-title":"BMC Public Health"},{"issue":"6","key":"10646_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/inthealth\/ihz043","volume":"11","author":"JS Sifa","year":"2019","unstructured":"Sifa JS, Manortey S, Talboys S, Ansa GA, Houphouet EE. Risk factors for loss to follow-up in human immunodeficiency virus care in the Greater Accra Regional Hospital in Ghana: a retrospective cohort study. Int Health. 2019;11(6):605\u201312.","journal-title":"Int Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10646-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10646-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10646-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:48:49Z","timestamp":1741243729000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10646-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10646"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10646-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"6 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board (IRB) of Jimma University (Ref. No. IHPPGJ\\7080\\22). Official supporting letters were provided to the Director of the Institute of Health and the ART Department of the Hospital. All collected data were kept confidential, and patient medical record numbers were used to differentiate study participants during data collection. Secondary data retrieved from the patient cards\/databases which had already been collected for ART care, were used in this study. Due to the challenges and impracticality of reaching individual HIV Patients, individual-level written informed consent was not sought. Instead, the Ethical Review Board (IRB) of the University waived the requirement for written consent, which was approved by Health facilities\u2019 offices. The hospital database management department had previously obtained consent from each HIV\/AIDS patient to use their data for research purposes in a confidential manner during their enrolment in the ART program.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declare that they have agreed to the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}